ZEISS Group, a privately owned company headquartered in Germany, was founded in 1846, employs approximately 38,770 individuals, and reported $13.4B in revenue as of 2025. The company's primary product is content acquisition, functioning as a tier 3 media tech buyer. ZEISS operates in the fields of optics and optoelectronics, with segments including Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets.
On September 17, 2026, ZEISS Medical Technology expanded its retinal imaging portfolio by introducing the ZEISS ALTA DUO 300, a fully automated compact multimodal imaging solution that combines OCT and fundus imaging to support efficient retinal assessment. Also that day, a case study reported consistent outcomes across 200 consecutive eyes in establishing a premium ZEISS PRESBYOND practice, which aims to reduce presbyopic patients' need for glasses in daily activities. An earlier report from September 17 discussed ZEISS's "Factory of the Future" philosophy, moving quality control in manufacturing from a defensive role to an integrated operating system designed to prevent scrap, rework, and costly failures. Previously, on September 16, ZEISS launched the VersaXRM 5 Insight, a hybrid 3D X-ray microscope that integrates X-ray microscopy and microCT in a single platform, offering multi-scale imaging, guided workflows, and automated AI-enabled reconstruction to help researchers and engineers understand samples faster through efficient non-destructive 3D imaging.
Similar Companies
Subscribe for full access to ZEISS Group's profile
ZEISS Group offers products in the media tech industry. ZEISS Group's product portfolio comprises of content acquisition.
Subscribe for full access to ZEISS Group's products in full detail
ZEISS Group's revenues were over $1B in 2025. All the revenue comes from camera lenses.
Subscribe for full access to ZEISS Group's revenue in full detail
Subscribe for full access to ZEISS Group's products in full detail 
